IOX1 impedes host inflammation in imiquimod-triggered psoriasis

Psoriasis is a chronic autoimmune disease with an unknown etiology and highly limited treatment strategies. The drugs currently used in the treatment of psoriasis are rarely recommended for long-term use owing to the serious side effects. Although different targets have been identified for controlli...

Descripción completa

Detalles Bibliográficos
Autores principales: Shin, Joo Eun, Lee, Su Jin, Gharbi, Amal, Jung, In Duk, Park, Yeong Min
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8632842/
https://www.ncbi.nlm.nih.gov/pubmed/34877426
http://dx.doi.org/10.1016/j.heliyon.2021.e08433

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8632842/
https://www.ncbi.nlm.nih.gov/pubmed/34877426
http://dx.doi.org/10.1016/j.heliyon.2021.e08433

Ejemplares similares